Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Concurrent once-daily versus twice-daily chemoradiotherap... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
0
Authors
C. Faivre‐Finn
19 more
C. Faivre‐Finn
•
Fabrice Barlési
17 more
•
Fiona Blackhall
Published
June 20, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Medicine
Cancer Oncology
Epidemiology
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1470-2045(17)30318-2
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Medicine
Cancer Oncology
Epidemiology
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1470-2045(17)30318-2
License
CC-BY
Other Formats
PDF
